SCHEMBL4138979

SCHEMBL4138979

CC(C)(C)OC(=O)NC[C@@H]1C[C@H]1c1cccc(-c2ccc(C(F)(F)F)cc2)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2C P28335 4/20 0.43
HTR2A P28223 1/20 0.42
HTR2B P41595 1/20 0.42
MGLL Q99685 3/20 0.42
DGAT2 Q96PD7 1/20 0.41
MDM2 Q00987 1/20 0.41
HDAC1 Q13547 1/20 0.39
APOB P04114 1/20 0.39
MTTP P55157 1/20 0.39
RXRA P19793 2/20 0.38
NR1H2 P55055 2/20 0.38
NR1H3 Q13133 2/20 0.38
KDM1A O60341 1/20 0.38
MAOA P21397 1/20 0.38
MAOB P27338 1/20 0.38
P2RY14 Q15391 1/20 0.38
ACACB O00763 2/20 0.38
ACACA Q13085 2/20 0.38
TACR1 P25103 1/20 0.38
PAX8 Q06710 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4138978 1.00 HTR2C (0.43) HTR2CHTR2AHTR2BMGLLDGAT2
SCHEMBL4127039 0.90 HTR2C (0.56) HTR2CHTR2AHTR2BMGLLHDAC1
SCHEMBL4127041 0.90 HTR2C (0.56) HTR2CHTR2AHTR2BMGLLHDAC1
SCHEMBL4126474 0.89 HTR2C (0.48) HTR2CDGAT2MDM2KDM1AMAOA
SCHEMBL4126477 0.89 HTR2C (0.48) HTR2CDGAT2MDM2KDM1AMAOA
SCHEMBL4129089 0.88 HTR2C (0.56) HTR2CHTR2AHTR2BMDM2HDAC1
SCHEMBL4129091 0.88 HTR2C (0.56) HTR2CHTR2AHTR2BMDM2HDAC1
SCHEMBL4126445 0.85 CTSS (0.41) HTR2CHDAC1KDM1AMAOAMAOB
SCHEMBL4126442 0.85 CTSS (0.41) HTR2CHDAC1KDM1AMAOAMAOB
SCHEMBL5315320 0.84 HTR2C (0.50) HTR2CHTR2AHTR2BMGLLHDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090203750-A1 5-HT2C Receptor Agonists as Anorectic Agents NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2009-08-13 US disclosed
WO-2007025144-A1 5-HT2C RECEPTOR AGONISTS AS ANORECTIC AGENTS UNIVERSITY OF ILLINOIS - CHICAGO (US) 2007-03-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090203750-A1 5-HT2C Receptor Agonists as Anorectic Agents HTR2C, HTR2A, HTR5A HTR2C 1/4885HTR2A 2/4885HTR2B 4/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.